Drug comparisons
Bexagliflozin vs Tolazamide
Compare Bexagliflozin vs Tolazamide for type 2 diabetes. SGLT2 inhibitor vs sulfonylurea: mechanisms, hypo risk, weight, CV benefits, and side effects.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for type 2 diabetes patients considering a switch from an older sulfonylurea to a newer SGLT2 inhibitor due to hypoglycemia, weight, or organ protection concerns.
Bottom line
Bexagliflozin generally provides a more favorable efficacy and safety profile than Tolazamide for most type 2 diabetes patients.
All medication comparisons